ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
BioNTech SE

BioNTech SE (22UA)

109.20
0.70
(0.65%)
Closed December 26 4:00PM
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
109.20
Bid
109.20
Ask
109.80
Volume
25,943
107.10 Day's Range 109.90
69.55 52 Week Range 118.50
Market Cap
Previous Close
108.50
Open
108.00
Last Trade
12
@
108.9
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
40,246
Shares Outstanding
237,725,735
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
3.82B
Net Profit
930.3M

About BioNTech SE

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Mainz, Deu
Founded
-
BioNTech SE is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker 22UA. The last closing price for BioNTech was 108.50 €. Over the last year, BioNTech shares have traded in a share price range of 69.55 € to 118.50 €.

BioNTech currently has 237,725,735 shares outstanding. The market capitalization of BioNTech is 25.79 € billion.

22UA Latest News

BioNTech kündigt Übernahme von Biotheus zur beschleunigten Umsetzung der Onkologie-Strategie an

BioNTech kündigt Übernahme von Biotheus zur beschleunigten Umsetzung der Onkologie-Strategie an Übernahme soll globale Umsetzung von BioNTechs Onkologie-Strategie unterstützen und die weltweiten...

BioNTech to Acquire Biotheus to Boost Oncology Strategy

BioNTech to Acquire Biotheus to Boost Oncology Strategy Acquisition to support the global execution of BioNTech’s oncology strategy and provide full global rights to BNT327/PM8002, an...

BioNTech veröffentlicht Ergebnisse für das dritte Quartal 2024 sowie Informationen zur Geschäftsentwicklung

BioNTech veröffentlicht Ergebnisse für das dritte Quartal 2024 sowie Informationen zur Geschäftsentwicklung Veröffentlichung klinischer Daten für mehrere Produktkandidaten aus verschiedenen...

BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update

BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update Presented clinical data for multiple assets across modalities, including bispecific antibody candidate BNT327/PM8002...

BioNTech veranstaltet am 14. November 2024 „Innovation Series Day“ zu Forschung & Entwicklung

BioNTech veranstaltet am 14. November 2024 „Innovation Series Day“ zu Forschung & Entwicklung MAINZ, Deutschland, 31. Oktober 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“...

BioNTech to Host Innovation Series R&D Day on November 14, 2024

BioNTech to Host Innovation Series R&D Day on November 14, 2024 MAINZ, Germany, October 31, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), will host an...

BioNTech veröffentlicht am 4. November 2024 Ergebnisse für das dritte Quartal 2024 und informiert über operativen Fortschritt

BioNTech veröffentlicht am 4. November 2024 Ergebnisse für das dritte Quartal 2024 und informiert über operativen Fortschritt MAINZ, Deutschland, 21. Oktober 2024 (GLOBE NEWSWIRE) -- BioNTech SE...

BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024

BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024 MAINZ, Germany, October 21, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the...

BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day

BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy...

BioNTech stellt auf dem ersten „AI Day” ihre Fähigkeiten im Bereich Künstliche Intelligenz und deren Anwendung in der Forschung und Entwicklung vor

BioNTech stellt auf dem ersten „AI Day” ihre Fähigkeiten im Bereich Künstliche Intelligenz und deren Anwendung in der Forschung und Entwicklung vor BioNTech stellt vor, wie unternehmenseigene...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-4.9-4.29447852761114.1114.3104.538197108.9429125DE
41.21.11111111111108118.5104.544598112.53246155DE
122.32.1515434986106.9118.589.5540246106.58069934DE
2630.60000138.931299477578.599999118.569.554365496.13019402DE
5214.214.947368421195118.569.554283391.93017427DE
156-124.1-53.1933133305233.3235.969.5576247131.98693456DE
26031.2407839565.5127303163.67088047DE

22UA - Frequently Asked Questions (FAQ)

What is the current BioNTech share price?
The current share price of BioNTech is 109.20 €
How many BioNTech shares are in issue?
BioNTech has 237,725,735 shares in issue
What is the market cap of BioNTech?
The market capitalisation of BioNTech is EUR 25.79B
What is the 1 year trading range for BioNTech share price?
BioNTech has traded in the range of 69.55 € to 118.50 € during the past year
What is the reporting currency for BioNTech?
BioNTech reports financial results in EUR
What is the latest annual turnover for BioNTech?
The latest annual turnover of BioNTech is EUR 3.82B
What is the latest annual profit for BioNTech?
The latest annual profit of BioNTech is EUR 930.3M
What is the registered address of BioNTech?
The registered address for BioNTech is AN DER GOLDGRUBE 12, MAINZ, 55131
What is the BioNTech website address?
The website address for BioNTech is www.biontech.de
Which industry sector does BioNTech operate in?
BioNTech operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0RARAPT Therapeutics Inc
1.61 €
(101.25%)
83.81k
KASHIntellabridge Technology Corp
0.047 €
(88.00%)
1.24M
4APApollo Minerals Ltd
0.01 €
(66.67%)
30
AWY0Percheron Therapeutics Ltd
0.007 €
(55.56%)
660k
1W81WISeKey International Holding Ltd
9.70 €
(44.78%)
4.81k
013CJDcom Inc
17.426 €
(0.00%)
0
013AJD.com Inc
34.90 €
(0.00%)
0
0110Thesis Gold Inc
0.391 €
(0.00%)
0
00WAspermont Ltd
0.004 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0
D7GNel ASA
0.2496 €
(-0.79%)
3.89M
RQ0DWave Quantum Inc
7.896 €
(24.07%)
2.16M
FWR0Yumy Candy Company Inc the
0.0352 €
(40.80%)
2.12M
PF8European Lithium Limited
0.0204 €
(-0.97%)
2.07M
DI6Distribuidora Internacional De Alimentacion SA
0.017 €
(1.80%)
1.83M

Discussion

View Full Feed
europa7 europa7 4 minutes ago
"Germany Rejects Chinese Carbon Credits Amid Fraud Concerns..." ~ Blockchain For Energy
Nov 28, 2024
https://x.com/Blockchain4NRG/status/1862156537646518433
"...Germany's Federal Environment Agency (UBA) has rejected carbon credits from Chinese projects. The need for transpare
HBARUSD
TrendTrade2016 TrendTrade2016 4 minutes ago
OH SHIT...AT 62 MY EYES ARE NOT LIKE THEY USE TO BE..YOU WILL GET THERE SOME DAY....AND WHY DO YOU CARE...AS ONE OF THE MAIN BASHERS...WHY WOULD YOU BE CONCERNED ABOUT MY CAPS...MAYBE YOU ARE A BAGHOLDER AND ARE UPSET AT GEORGE FOR STEALING YOUR MONEY!
GVSI
Angelmin Angelmin 4 minutes ago
Yes! 
Price predictions: $10 for January 20th release, $20 for confirmation of FHFA head, $30 for relisting.

To the moon!
FNMA
Monksdream Monksdream 4 minutes ago
ZCAR, there it goes maybe
ZCAR
TJG TJG 4 minutes ago
This looks like its ready to test the 52 week high's very positive news again this morning... on the footsteps of the Dec 23 clinical study results

https://www.otcmarkets.com/stock/RDGL/news/Vivos-Incs-IsoPet-Division-Achieves-Exceptional-Growth-in-2024-Expanding-Certified-Veterinary
RDGL
tw0122 tw0122 4 minutes ago
$7.10
PDYN
Paulness Paulness 5 minutes ago
NEWS -- Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide

https://media.zenfs.com/en/globenewswire.com/596a9a524bfac144adaabea16328ae5b

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB:
RDGL
iamthe walrus iamthe walrus 5 minutes ago
Most info i found in todays [Correction of statement]Semi-annual Report is just a lot of previuos company info and financial info but some info is interesting like this entry .

024.02.14 Conclusion of a single sales/supply contract. KIB has some good clientele

(Correc
CRTG
flipper44 flipper44 5 minutes ago
From the NWBO patent application.

In one embodiment, the hyperactive mature dendritic cells produced by any of the above methods are used for producing a medicament for treating cancer, particularly a solid tumor, a bacterial infection, or a viral infection.

https://pat
NWBO
KILLAZILLA KILLAZILLA 5 minutes ago
you SHOULD TAKE your OWN ADVICE!!!
XERI
AugustaFriends AugustaFriends 6 minutes ago
$SES I loaded this morning 14,000 shares -- Break 1.05 my Target $1.90
SES
Hoskuld Hoskuld 6 minutes ago
Will be nice when a tier one investment bank issues an opinion about $AVXL share value.
AVXL
tw0122 tw0122 7 minutes ago
Ok $12.13 + 23%
CYD
marcis marcis 7 minutes ago
Hey Ihub admin Shelly

What’s with these two of three stickies?
RDAR
Monksdream Monksdream 7 minutes ago
PDYN there it goes
PDYN
miketherage miketherage 8 minutes ago
This is hilarious.  So it should trade at revenue.... so then nvidia value is $9
COIN
dexprs dexprs 8 minutes ago
Looks like a negative open for the "Santa Rally's" first day. I will assume it will happen and trade accordingly.
surfkast surfkast 8 minutes ago
Your caps lock is stuck. SMH
GVSI
HGilS HGilS 9 minutes ago
Thanks my friend - text me :-)
ELTP
sam1933 sam1933 9 minutes ago
https://investorshub.advfn.com/static/images/ih2-bull.png https://media1.tenor.com/m/kDouO742socAAAAd/hedera-hashgraph-hedera.gif
https://media1.tenor.com/m/94cg8WWC-MQAAAAd/hedera-hashgraph.gif
HBARUSD
Yo-Yo Yo-Yo 9 minutes ago
CYN was just $1.60 on 12-19-2024, can she make it back or close to that , pass $1.00 and who knows 
tw0122 tw0122 9 minutes ago
$6.56.. style="font-size: initial; font-weight: bold; caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: arial, helvetica, sans-serif; background-color: rgba(255, 255, 255, 1)" Palladyne AI Achieves Key Milestone with First Small Drone Autonomous Tracking Flight
PDYN
Julesb Julesb 10 minutes ago
If you stay on this page, look under quote. You have tabs for quote, board etc. click on trades and it shows premarket.
ELTP
Large Green Large Green 10 minutes ago
Hey Fred, even though just a mouse click why would the Big Money Players allow a distribution by yearend unless NONTAXABLE?

This dies not make sense but would cherish anything credible and anytime!


Golden Cross Golden Cross 10 minutes ago
$GRLF JRCStockTalk Live Stream Q&A with $GRLF

https://www.youtube.com/live/C-GFgzY6Zmc

[yt]C-GFgzY6Zmc[/yt]
GRLF

Your Recent History

Delayed Upgrade Clock